DXCM
Price
$87.90
Change
-$1.81 (-2.02%)
Updated
Sep 4 closing price
Capitalization
33.17B
47 days until earnings call
Intraday BUY SELL Signals
NVST
Price
$27.28
Change
-$0.31 (-1.12%)
Updated
Sep 4, 04:59 PM (EDT)
Capitalization
4.43B
61 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DXCM vs NVST

DXCM vs NVST Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DXCM vs. NVST commentary
Sep 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DXCM is a Hold and NVST is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2026
Stock price -- (DXCM: $87.90 vs. NVST: $27.28)
Brand notoriety: DXCM and NVST are both not notable
DXCM represents the Medical/Nursing Services, while NVST is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DXCM: 42% vs. NVST: 63%
Market capitalization -- DXCM: $33.17B vs. NVST: $4.38B
DXCM [@Medical/Nursing Services] is valued at $33.17B. NVST’s [@Pharmaceuticals: Other] market capitalization is $4.38B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $187.45B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $129.55B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.81B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXCM’s FA Score shows that 2 FA rating(s) are green whileNVST’s FA Score has 0 green FA rating(s).

  • DXCM’s FA Score: 2 green, 3 red.
  • NVST’s FA Score: 0 green, 5 red.
According to our system of comparison, DXCM is a better buy in the long-term than NVST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXCM’s TA Score shows that 3 TA indicator(s) are bullish while NVST’s TA Score has 6 bullish TA indicator(s).

  • DXCM’s TA Score: 3 bullish, 5 bearish.
  • NVST’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, NVST is a better buy in the short-term than DXCM.

Price Growth

DXCM (@Medical/Nursing Services) experienced а -3.22% price change this week, while NVST (@Pharmaceuticals: Other) price change was +0.55% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.20%. For the same industry, the average monthly price growth was -1.16%, and the average quarterly price growth was -5.15%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.63%. For the same industry, the average monthly price growth was +1.98%, and the average quarterly price growth was +11.27%.

Reported Earning Dates

DXCM is expected to report earnings on Oct 22, 2026.

NVST is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Medical/Nursing Services (-4.20% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-0.63% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DXCM($33.2B) has a higher market cap than NVST($4.43B). NVST has higher P/E ratio than DXCM: NVST (47.57) vs DXCM (34.74). DXCM YTD gains are higher at: 32.439 vs. NVST (27.084). DXCM has higher annual earnings (EBITDA): 1.56B vs. NVST (388M). DXCM has more cash in the bank: 1.95B vs. NVST (1.08B). DXCM has less debt than NVST: DXCM (1.4B) vs NVST (1.59B). DXCM has higher revenues than NVST: DXCM (4.97B) vs NVST (2.81B).
DXCMNVSTDXCM / NVST
Capitalization33.2B4.43B749%
EBITDA1.56B388M402%
Gain YTD32.43927.084120%
P/E Ratio34.7447.5773%
Revenue4.97B2.81B177%
Total Cash1.95B1.08B180%
Total Debt1.4B1.59B88%
FUNDAMENTALS RATINGS
DXCM vs NVST: Fundamental Ratings
DXCM
NVST
OUTLOOK RATING
1..100
3984
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
2587
PRICE GROWTH RATING
1..100
2145
P/E GROWTH RATING
1..100
8676
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (61) in the null industry is in the same range as DXCM (82) in the Medical Specialties industry. This means that NVST’s stock grew similarly to DXCM’s over the last 12 months.

NVST's Profit vs Risk Rating (100) in the null industry is in the same range as DXCM (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to DXCM’s over the last 12 months.

DXCM's SMR Rating (25) in the Medical Specialties industry is somewhat better than the same rating for NVST (87) in the null industry. This means that DXCM’s stock grew somewhat faster than NVST’s over the last 12 months.

DXCM's Price Growth Rating (21) in the Medical Specialties industry is in the same range as NVST (45) in the null industry. This means that DXCM’s stock grew similarly to NVST’s over the last 12 months.

NVST's P/E Growth Rating (76) in the null industry is in the same range as DXCM (86) in the Medical Specialties industry. This means that NVST’s stock grew similarly to DXCM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DXCMNVST
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 5 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 5 days ago
69%
Bullish Trend 2 days ago
66%
Declines
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 8 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
73%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
DXCM
Daily Signal:
Gain/Loss:
NVST
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JPO14.500.26
+1.83%
YieldMax JP Option Income Strategy ETF
SFY153.581.89
+1.25%
SoFi Select 500 ETF
MYCO23.830.08
+0.35%
State Street® My2035 Corporate Bond ETF
SPSB29.810.02
+0.07%
State Street® SPDR® S/t Corp Bd ETF
AAOX9.80-0.62
-5.95%
Tradr 2X Long AAOI Daily ETF